Your browser doesn't support javascript.
loading
Unrelated cord blood transplantation vs. HLA-matched sibling transplantation for adults with B-cell acute lymphoblastic leukemia in complete remission: superior OS for patients with long-term survival.
Sun, Guangyu; Tang, Baolin; Song, Kaidi; Wu, Yue; Tu, Meijuan; Wan, Xiang; Yao, Wen; Geng, Liangquan; Qiang, Ping; Zhu, Xiaoyu.
Afiliação
  • Sun G; Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China.
  • Tang B; Anhui Provincial Key Laboratory of Blood Research and Applications, Hefei, China.
  • Song K; Blood and Cell Therapy Institute, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Wu Y; Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China.
  • Tu M; Anhui Provincial Key Laboratory of Blood Research and Applications, Hefei, China.
  • Wan X; Blood and Cell Therapy Institute, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Yao W; Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China.
  • Geng L; Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China.
  • Qiang P; Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China.
  • Zhu X; Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China.
Stem Cell Res Ther ; 13(1): 500, 2022 10 09.
Article em En | MEDLINE | ID: mdl-36210439
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Burkitt / Transplante de Células-Tronco Hematopoéticas / Transplante de Células-Tronco de Sangue do Cordão Umbilical / Leucemia-Linfoma Linfoblástico de Células Precursoras / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Stem Cell Res Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Burkitt / Transplante de Células-Tronco Hematopoéticas / Transplante de Células-Tronco de Sangue do Cordão Umbilical / Leucemia-Linfoma Linfoblástico de Células Precursoras / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Stem Cell Res Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido